Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Azilsartan

Azilsartan (TAK-536) is an orally active, potent, selective and specific angiotensin II type 1 receptor (AT1) antagonist. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. Azilsartan can be used for hypertension and stroke research[1][2][3][4][5].

Product Specifications

CAS Number

147403-03-0

Product Name Alternative

TAK-536

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Angiotensin Receptor; Apoptosis; Reactive Oxygen Species (ROS)

Type

Reference compound

Related Pathways

Apoptosis; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Metabolic Disease; Neurological Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Azilsartan.html

Purity

99.68

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C(N5)=NOC5=O)C=C3)=CC=C1)O

Molecular Formula

C25H20N4O5

Molecular Weight

456.45

Precautions

H302, H315, H319, H335

References & Citations

[1]Kajiya T, et al. Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker. J Hypertens. 2011 Dec;29 (12) :2476-83.|[2]Zhao M, et al. Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats. Diabetes Obes Metab. 2011 Dec;13 (12) :1123-9.|[3]Ojima M, et al. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J Pharmacol Exp Ther. 2011 Mar;336 (3) :801-8. |[4]Gupta V, et al. Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms. Neurochem Int. 2020 Jan;132:104604.|[5]Ahmadian E, et al. Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2. Biomed Pharmacother. 2018 Mar;99:939-946.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

AT1 Receptor

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Sodium Glycerophosphate Hydrate
289372-01 25 g

Sodium Glycerophosphate Hydrate

Sign In for Pricing
View Details
Sodium Glycerophosphate Hydrate
289372-02 100 g

Sodium Glycerophosphate Hydrate

Sign In for Pricing
View Details
Sodium Glycerophosphate Hydrate
289372-03 250 g

Sodium Glycerophosphate Hydrate

Sign In for Pricing
View Details
Sodium Glycerophosphate Hydrate
289372-04 500 g

Sodium Glycerophosphate Hydrate

Sign In for Pricing
View Details
(+) -Cloprostenol
T13461-01 5 mg

(+) -Cloprostenol

Sign In for Pricing
View Details
(+) -Cloprostenol
T13461-02 10 mg

(+) -Cloprostenol

Sign In for Pricing
View Details